LRLCY News and Press, L'Oreal S.A. ADR From 12/11/22

Summary Olaplex can afford to significantly increase its marketing costs because the company has abnormally high margins. The company's portfolio includes only 14 products, and management plans to release several new products annually. It seems that the market has already reflected ...

Summary In my opinion, Inter Parfums is a great company with growth potential that is currently fairly valued. In 2021, sales had increased by 23.4% compared to 2019 and reached USD 880 million, which represents an 11% sales growth CAGR since 2016, supported by strong industry tailwinds...

Summary EL's Q1 FY23 results were poor, with sales down 5% organically and Adjusted EBIT down 26%; FY23 outlook was cut. EL's peers grew their sales by 9% in the same quarter. EL's larger exposure to China explains part of the underperformance. COVID restrictions hit Travel Re...

Summary Fisher’s 13F portfolio value decreased from ~$141B to ~$133B in Q3 2022. They added Charles Schwab and increased Nvidia, Morgan Stanley, and Goldman Sachs while decreasing Salesforce, Visa, Alibaba Group Holdings, Novartis, Verizon, and Tencent Holdings. The top...

Summary Unilever PLC is a great long-term, slow-growth, bond-equivalent name. Cost inflation fears and currency have hit the ADRs hard this year, sending Unilever stock's P/E ratio to its lowest level in years. Unilever has managed itself well through this challenging operatin...

Summary Valuation is core to everything that I do - second to nothing. The current valuation trends on a high level, for the overall stock markets, show very clear indications. Those indications are that several markets are currently significantly undervalued - on a very broad bas...

L'Oréal (ENXT: OR) (OTC: LRLCY) might seem like a great stock to buy as inflation, rising interest rates, and other macro headwinds rattle the broader markets. The French cosmetics giant -- which also owns Lancôme, Maybelline, NYX Cosmetics, and Garnier -- mainly targe...

Summary All divisions achieved good growth, especially the division related to dermatological products. The weak euro has greatly facilitated growth in each division. The dividend yield is still too low and capital gain expectations are not that high being a consumer staples. ...

Summary The French cosmetics company L'Oreal isn't just a market leader, its recent sales growth has been robust and its margins are enviable. But can it sustain its performance considering its muted long-term growth? It would appear so, going by its rising digital sales. Its ...

US-listed shares of L’Oreal SA ( OTCPK:LRLCY ) gained on Thursday after the company posted strong Q3 sales, bolstered by resilient demand for cosmetics and consumer products. The French beauty giant posted €27.94B, up from €23.19B in the year prior. ...